Irvine, David A.
Zhang, Bin
Kinstrie, Ross
Tarafdar, Anuradha
Morrison, Heather
Campbell, Victoria L.
Moka, Hothri A.
Ho, Yinwei
Nixon, Colin
Manley, Paul W.
Wheadon, Helen
Goodlad, John R.
Holyoake, Tessa L.
Bhatia, Ravi
Copland, Mhairi
Article History
Received: 24 September 2015
Accepted: 18 April 2016
First Online: 9 May 2016
Competing interests
: PWM is an employee of Novartis Institutes for Biomedical Research. TLH has received research funding from Novartis and Bristol-Myers Squibb, is an advisory board member for Novartis and Ariad and has received honoraria from Bristol-Myers Squibb, Novartis and Ariad. RB has received research funding from Novartis, has been an advisory board member and has received honoraria from Novartis, Bristol-Myers Squibb and Teva. MC has received research funding from Novartis and Bristol-Myers Squibb, is an advisory board member for Bristol-Myers Squibb, Novartis, Ariad and Pfizer and has received honoraria from Bristol-Myers Squibb, Novartis, Ariad and Pfizer. The other authors have no additional financial interests.